Sign in
Taking people in United StatesNo phase

Testing new biomarker tests on pleural biopsies in pleural mesothelioma

Tests a new method to judge stage and outlook in pleural mesothelioma.

Key facts

Who runs it
Dana-Farber Cancer Institute
Where
Boston, United StatesSee the site
Trial code
Registry title
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Status
Recruiting
People taking part
240 people, planned
Started
31 Oct 2018
Expected to end
1 Oct 2030
Type of study
Interventional
Treatments tested
  • MPT Test
  • CLDN15/VIM Test
Record updated
5 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with malignant pleural mesothelioma who are having a pleural biopsy, pleuroscopy or VATS surgery.

Age
18 years or older
Sex
Men and women can join
Disease stage
Malignant pleural mesothelioma, diagnosed

Main reasons for not taking part

  • Anyone found to be unsuitable for surgery, treatment or diagnosis

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • All adult patients with a diagnosis of malignant pleural mesothelioma undergoing; diagnostic pleural biopsy; pleuroscopy; and/or VATS resections
  • Participants must be 18 years of age or older

Who cannot take part

  • surgery,
  • -Any patient who is found to be unsuitable for
  • treatment
  • diagnosis,

Where in United States

  • Brigham and Women's HospitalBoston, United StatesContact: Raphael Bueno, MDTaking people

About the trial

What the trial wants to find out

This research study is evaluating a new method for determining stage and prognosis of individuals with malignant pleural mesothelioma.

The group in the trial

  • MRiSTreatment being tested

    * The specimens to be collected will include at least five pleural biopsy samples * MPT test and the CLDN15/VIM test will be performed

    Treatment: MPT Test and CLDN15/VIM Test

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers
Plain-language title
Testing new biomarker tests on pleural biopsies in pleural mesotheliomaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
5 May 2026